Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 13, 2026
Why Is Tapestry (TPR) Stock Down -15.29% Today?

Why Is Tapestry (TPR) Stock Down -15.29% Today?

Key Takeaways

  • Direction and magnitude: TPR fell 15.29% in morning trading Thursday, last changing hands at $130.24, down $23.50 from Wednesday's close of $153.74.
  • Primary catalyst: A fiscal fourth-quarter earnings beat was overshadowed by fiscal 2027 revenue guidance whose midpoint of $8.45 billion landed below analyst expectations.
  • Secondary drivers: Continued sales declines at Kate Spade, tariff assumptions embedded in the outlook, and an elevated valuation after a strong run left little room for an in-line forecast.
  • Positive details the market largely ignored: Coach revenue rose 15%, full-year revenue increased 14%, and the board approved a 16% dividend increase.
  • Broader context: The sell-off was stock-specific and followed a 4.2% decline in the prior session.
  • What traders are watching next: Analyst estimate revisions, Coach momentum versus Kate Spade stabilization, tariff and consumer-demand signals, and technical support levels.

Opening Summary

Tapestry, Inc. (TPR), the New York-based house of accessories and lifestyle brands behind Coach and Kate Spade New York, saw its shares plunge Thursday after a quarterly report that beat profit expectations but failed to satisfy investors looking for stronger forward guidance. The stock tumbled 15.29% to $130.24 as of 9:46 a.m. ET, compared with a prior-session close of $153.74. The decline followed the company's fiscal 2026 fourth-quarter release, which showed solid execution at Coach but renewed concerns about slowing growth, persistent Kate Spade weakness, and a valuation that had already priced in outperformance.

Earnings Results and Guidance

The company delivered fourth-quarter net sales of $1.88 billion, up 9% year over year, and adjusted earnings per share of $1.32, up 28% from the prior year and ahead of consensus forecasts. For the full fiscal year, revenue reached $8.0 billion, an increase of 14%, while adjusted EPS rose 38% to $7.05. Coach remained the clear growth engine, with fourth-quarter revenue up 15% and full-year revenue up 24%.

The problem was the outlook. Tapestry initiated fiscal 2027 revenue guidance of $8.4 billion to $8.5 billion, implying mid-single-digit growth and a midpoint of $8.45 billion, slightly below the roughly $8.47 billion analysts had modeled. EPS guidance of $7.80 to $7.90 was largely in line with expectations, and first-quarter EPS guidance of about $1.55 came in above consensus, but the revenue forecast signaled a meaningful deceleration from the double-digit growth of fiscal 2026. The earnings-driven move showed that investors were focused on the growth trajectory rather than the quarterly beat.

Kate Spade Remains the Weak Link

While Coach continued to gain share and expand its handbag average unit retail, Kate Spade remained a drag. Fourth-quarter Kate Spade revenue fell 7% year over year, and full-year brand revenue declined 10%, as the company pulled back on promotions and worked through a strategic reset. The contrast reinforced concerns about Tapestry's reliance on Coach for the majority of growth and profitability.

Tariff considerations also featured in the guidance. The company's fiscal 2027 plan embeds a mid-20% tariff rate on U.S. inventory receipts and assumes a neutral net tariff impact year over year. In the fourth quarter, tariff and duty effects partially offset operational margin gains, and the outlook's modest operating-margin expansion of about 50 basis points left investors questioning how much cost leverage is available if consumer demand softens.

Elevated Expectations and Valuation

The sharp market reaction reflected how much optimism was already embedded in the stock. TPR had rallied powerfully over the past year, reaching a 52-week high above $160 earlier in 2026, before entering Thursday's session with a modest pullback that included a 4.2% decline the prior day. With the shares trading at a rich valuation relative to their historical norm, an in-line-to-lighter revenue forecast and continued Kate Spade softness triggered profit-taking and a sell-the-news response.

Market Context and Trading Activity

The move was primarily company-specific, driven by the earnings release and guidance rather than a broad consumer-discretionary event. Trading was active as investors absorbed the report, and the stock traded just above its morning low of $130.17. The decline pushed shares decisively below the $140 and $150 levels and well off the 52-week high, underscoring the speed with which sentiment shifted following the outlook. The company also announced shareholder-friendly actions, including a 16% dividend increase to an annual rate of $1.85 per share and plans to repurchase approximately $1.35 billion in stock during fiscal 2027, but those steps were not enough to offset the growth concerns.

What Comes Next for TPR

Investors will now watch how analysts adjust full-year estimates and whether the stock can stabilize after the post-earnings reset. The company's fiscal 2027 first-quarter results are scheduled for November 5, 2026, and that update will offer an early read on Coach's momentum, Kate Spade's progress, and the impact of tariffs on margins. Key risks include a slowdown in consumer discretionary spending, potential trade-policy escalation, foreign-exchange swings, and execution at Kate Spade. The path of the stock will likely depend on whether management can sustain Coach's strength while improving the rest of the portfolio against a more uncertain macro backdrop.

Trending AI Robots

Tickeron's Trending AI Robots page highlights a curated selection of AI-driven trading bots that are performing strongly under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, with strategies that vary by timeframe, performance metrics, and traded symbols. Traders tracking TPR may find the page useful for identifying systematically selected approaches across today's market environment.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TPR

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


TPR sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for TPR moved below the 200-day moving average on September 11, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TPR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

The Aroon Indicator for TPR entered a downward trend on October 01, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where TPR's RSI Indicator exited the oversold zone, 15 of 19 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Momentum Indicator moved above the 0 level on October 01, 2026. You may want to consider a long position or call options on TPR as a result. In 65 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 76%.

The Moving Average Convergence Divergence (MACD) for TPR just turned positive on September 16, 2026. Looking at past instances where TPR's MACD turned positive, the stock continued to rise in 27 of 38 cases over the following month. The odds of a continued upward trend are 71%.

Following a +4.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where TPR advanced for three days, in 236 of 321 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

TPR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 32 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. TPR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TPR's P/B Ratio (32.680) is very high in comparison to the industry average of (6.448). P/E Ratio (15.605) is within average values for comparable stocks, (16.915). TPR's Projected Growth (PEG Ratio) (1.624) is slightly higher than the industry average of (0.396). Dividend Yield (0.015) settles around the average of (0.036) among similar stocks. TPR's P/S Ratio (3.097) is slightly higher than the industry average of (1.399).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Signet Jewelers Limited (NYSE:SIG), Capri Holdings Limited (NYSE:CPRI), RealReal (The) (NASDAQ:REAL).

Industry description

The catalog and specialty distribution industry includes companies that offer retail through mail-order houses, media, online social platforms, mobile apps and other channels outside of brick-and-mortar stores. Several companies in this business partner with retail companies to assist them with marketing, digital solutions, warehousing, and/or other distribution capabilities. In essence, the industry acts as a potential catalyst for retailers/brands to widen their reach among customers. Pinduoduo Inc., Qurate Retail, Inc. and Baozun are some of the major players in this business.

Market Cap

The average market capitalization across the Catalog/Specialty Distribution Industry is 3.19B. The market cap for tickers in the group ranges from 120.92K to 223.68B. LVMUY holds the highest valuation in this group at 223.68B. The lowest valued company is SSOK at 120.92K.

High and low price notable news

The average weekly price growth across all stocks in the Catalog/Specialty Distribution Industry was -1%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was -5%. REAL experienced the highest price growth at 6%, while LANV experienced the biggest fall at -12%.

Volume

The average weekly volume growth across all stocks in the Catalog/Specialty Distribution Industry was -5%. For the same stocks of the Industry, the average monthly volume growth was -23% and the average quarterly volume growth was -19%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 81
Price Growth Rating: 56
SMR Rating: 66
Profit Risk Rating: 84
Seasonality Score: 33 (-100 ... +100)
View a ticker or compare two or three
TPR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a designer of luxury accessories and lifestyle brands

Industry CatalogSpecialtyDistribution

Industry
Apparel Or Footwear Retail
Address
10 Hudson Yards
Phone
+1 212 946-8400
Employees
20600
Web
https://www.tapestry.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Why Is Tapestry (TPR) Stock Down -15.29% Today?